Novo Nordisk today announced sales and operating profit growth at constant exchange rates (CER) for 2025 and released the 2026 full-year sales and operating profit outlook at CER. 2025 sales and ...

Data sovereignty key navigating 340B's future helps healthcare leaders build integrated data systems for compliance and ...

The federal government has dropped its appeal of a preliminary injunction blocking implementation of the Department of Health ...

Let’s talk about 340B, the drug pricing problem that you may not have heard of, but the one that seems to have swallowed the federal budget. The program started as an attempt to help hospitals that ...

Too many hospitals take advantage of 340B, intended to make medications affordable for low-income patients. A New York proposal would make things worse. Credit: Getty Images. Millions of New Yorkers ...

A federal program for safety net hospitals — one that helps them purchase lifesaving and often highly expensive medicines at a major discount — is at risk of being significantly scaled back. Proposed ...

I am a proud health care professional here in Delaware, and I am calling on leaders in Washington, D.C. to support the 340B ACCESS Act. This legislation is urgently needed to restore accountability to ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Since 1992, the 340B drug discount program has entitled certain federal grantee clinics and hospitals (called “covered entities”) to purchase outpatient drugs at substantial discounts. The discounted ...

The 340B Drug Pricing Program was designed to help safety net providers serve low-income patients, but it has since ballooned into a multibillion-dollar system dominated by large health systems — with ...

In a move that will fundamentally change how the 340B Drug Pricing Program (“340B Program”) operates for a subset of medications, HRSA’s Office of Pharmacy Affairs (“OPA”) opted late last week to ...

The Trump administration has approved eight drugmakers' rebate plans for a controversial 340B drug discount pilot program that kicks off Jan. 1. The 340B Rebate Model Pilot Program, unveiled this ...